Manufacturing Challenges for Biosimilars: Why Copying Biologics Is Far Harder Than Generics
Biosimilars are far more complex to manufacture than generics because they're made from living cells, not chemicals. Copying a biologic requires matching intricate molecular details like glycosylation, scaling up production without losing quality, and meeting strict global regulations - making biosimilar manufacturing one of the toughest challenges in pharma.